MRO, a company dedicated to advancing data solutions in healthcare, has announced its acquisition of Clinetic, a prominent recruitment management platform. This move aims to bolster MRO’s commitment to delivering smarter data, although the financial specifics of the acquisition remain undisclosed.
Enhancing Patient Recruitment Through AI Integration
The integration of Clinetic’s AI-driven software represents a significant advancement in the recruitment processes for clinical trials. This innovative technology utilizes real-time data from Electronic Health Records (EHR) to streamline the identification, screening, and enrollment of patients. By addressing the challenges faced by healthcare providers, Clinetic’s platform enables hospitals to recruit participants with enhanced speed and accuracy.
Clinetic’s software is designed to integrate seamlessly with provider EHR systems, deploying secure connectors that operate behind firewalls. This direct access to comprehensive historical and clinical data allows research teams to meet the specific requirements of various clinical trial protocols effectively.
Utilizing this real-time data layer, research teams can accomplish several vital tasks: they can efficiently identify eligible patients across diverse therapeutic areas, build more precise patient cohorts, and plan studies with greater confidence.
Tom Kaminski, CEO of Clinetic, emphasized the strategic nature of this acquisition: “Clinetic has strong roots in healthcare, already evaluating the data of more than 15 million patients across the United States. Joining MRO was a natural fit, considering our joint focus on transforming unstructured clinical data into actionable data sets and our unwavering commitment to our hospital partners and the communities they serve.”
Impact on Clinical Trials and Healthcare
The collaboration between MRO and Clinetic is set to address the pressing resource and technology limitations that many hospitals face. As the demand for efficient clinical trial recruitment continues to grow, the integration of AI technology into this process is increasingly vital.
This acquisition highlights a broader trend in the healthcare sector toward leveraging data analytics and artificial intelligence to enhance patient engagement and support research initiatives. By improving recruitment capabilities, MRO and Clinetic aim to accelerate the development of new therapies and treatments, ultimately benefiting patients and healthcare providers alike.
As the healthcare landscape evolves, MRO’s strategic acquisition represents a significant step in the ongoing effort to optimize clinical trial processes and improve patient outcomes through innovative data solutions.
